Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting
Go back to Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting| (NASDAQ: ADIL) | Delayed: 2.74 -0.06 (2.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.80 | 52 Week High | $ | |||
| Open | $2.77 | 52 Week Low | $ | |||
| Day High | $2.77 | P/E | N/A | |||
| Day Low | $2.60 | EPS | $ | |||
| Volume | 21,557 | |||||
